Smith, M. R., Hong, F., Li, H., Gordon, L. I., Gascoyne, R. D., Paietta, E. M., . . . Kahl, B. S. (2016). Mantle Cell Lymphoma Initial Therapy with Abbreviated R-CHOP Followed by (90)Yibritumomab tiuxetan: Ten year follow-up of the Phase 2 ECOG-ACRIN study E1499. Leukemia.
Παραπομπή Chicago StyleSmith, Mitchell R., et al. "Mantle Cell Lymphoma Initial Therapy With Abbreviated R-CHOP Followed By (90)Yibritumomab Tiuxetan: Ten Year Follow-up of the Phase 2 ECOG-ACRIN Study E1499." Leukemia 2016.
Παραπομπή MLASmith, Mitchell R., et al. "Mantle Cell Lymphoma Initial Therapy With Abbreviated R-CHOP Followed By (90)Yibritumomab Tiuxetan: Ten Year Follow-up of the Phase 2 ECOG-ACRIN Study E1499." Leukemia 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.